The Medical Research Council (MRC), the UK Economic and Social Research Council (ESRC) and the Canadian Institutes of Health Research (CIHR) are pleased to invite proposals to the UK-Canada Diabetes Partnership Initiative.
The Japan Agency for Medical Research and Development (AMED) and the UK Medical Research Council (UKRI MRC) are pleased to launch a call for proposals for UK-Japan collaborative research into infectious diseases. This jointly funded initiative is aimed at fostering collaborative links between researchers in the UK and Japan.
The CRTF supports clinically active professionals within the UK to undertake a higher research degree. The scheme can also provide post-doctoral funding for applicants who achieved their PhD more than five years ago but who have not been research active since due to clinical training commitments.
The CSF develops talented medically and other clinically qualified professionals who have gained a higher research degree to lead their own research plans and establish their own research team to make the transition to independent investigator.
You can apply to the Molecular & Cellular Medicine Board through four of our grant schemes.
The UK MRC and South African MRC (SAMRC) are pleased to invite proposals to the South Africa – UK Antibiotic Accelerator under the umbrella of the Newton Fund.
This initiative will provide funding for high quality collaborative research partnerships focused on addressing the growing global burden of antimicrobial resistance, specifically antibacterial resistance in (South) Africa, through drug discovery.
This cross-council, UKRI GCRF Health and Context call is seeking proposals for interdisciplinary research addressing wider contextual factors contributing to the burden of infectious and non-communicable diseases.
This joint BBSRC, EPSRC and MRC 2019 Tools and Resources Development Fund (TRDF) call aims to pump prime the next generation of cutting-edge enabling research technologies with the potential for transformative impact in life sciences research.